Skip to main content

Table 2 Univariate analysis of risk factors for progression free survival (PFS) and overall survival (OS) in 91 patients

From: The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine

Prognostic factors

 

2-year PFS (%) [95% CI]

P value

2-year OS (%) [95% CI]

P value

Age (yeaars)

≤38

64.1(7.5)

0.142

81.8(6.3)

0.130

 

>38

89.6(5.0)

 

92.5(4.3)

 

Gender

Female

82.8(6.6)

0.513

88.9(5.3)

0.686

 

Male

72.7(6.5)

 

86.5(5.2)

 

KPS

≥90

80.1(4.8)

0.029

90.8(3.6)

0.008

 

80

53.0(15.5)

 

59.7(15.9)

 

Critical organ compression

Yes

71.1(5.8)

0.012

83.4(4.9)

0.048

 

No

95.7(4.3)

 

100

 

Cranial nerve injury

Yes

71.4(5.8)

0.011

83.5(4.8)

0.043

 

No

95.7(4.3)

 

100

 

Histology

Chordoma

73.5(5.5)

0.132

85.9(4.4)

0.340

 

Chondrosarcoma

92.9(6.9)

 

92.9(6.9)

 

GTV

≤60 cc

84.9(5.0)

0.004

93.9(3.4)

<0.001

 

>60 cc

59.7(9.5)

 

73.2(8.8)

 

Recurrent disease

Yes

73.8(6.9)

0.828

82.7(6.0)

0.260

 

No

80.4(6.4)

 

92.5(4.2)

 

Re-radiotherapy

Yes

41.3(15.7)

0.015

50.3(15.5)

<0.001

 

No

82.8(4.6)

 

93.8(3.0)

 

Surgery times

1

81.1(6.1)

0.609

87.7(5.2)

0.654

 

≥2

71.5(7.3)

 

86.3(5.7)

 

RT

Proton

100

0.69

100

0.489

 

Proton+carbon

74.2(8.4)

 

84.6(7.1)

 
 

Carbon

75.6(6.3)

 

87.3(5.1)